Genosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018

Press/Media: Press / Media

Period2018 May 16 → 2018 May 29

Media coverage

5

Media coverage

  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletPharmacy Choice
    CountryUnited States
    Date18/5/29
    URLwww.pharmacychoice.com/news/article.cfm?Article_ID=2017021
    PersonsJong Hyuk Sung
  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date18/5/17
    PersonsJong Hyuk Sung
  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletBusiness Wire
    CountryUnited States
    Date18/5/16
    PersonsJong Hyuk Sung
  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletBusiness Wire
    CountryUnited States
    Date18/5/16
    PersonsJong Hyuk Sung
  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletSpoke.com
    CountryUnited States
    Date18/5/16
    URLwww.spoke.com/press_releases/5afcb1dc2c33d47ab800e659
    PersonsJong Hyuk Sung